Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study

Background. Long-term use of many classic chemotherapeutic agents as adjuncts in the management of periodontitis has adverse complications, leading to seeking out naturopathic remedies. Although curcumin has been investigated in managing periodontitis, its therapeutic benefits have not been fully ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Veena HR, Riya Achamma Daniel, Ashwin Prabhu, Shilpa P, Suman Basavaraju
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2023-12-01
Series:Journal of Advanced Periodontology and Implant Dentistry
Subjects:
Online Access:https://japid.tbzmed.ac.ir/PDF/japid-15-67.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128078787444736
author Veena HR
Riya Achamma Daniel
Ashwin Prabhu
Shilpa P
Suman Basavaraju
author_facet Veena HR
Riya Achamma Daniel
Ashwin Prabhu
Shilpa P
Suman Basavaraju
author_sort Veena HR
collection DOAJ
description Background. Long-term use of many classic chemotherapeutic agents as adjuncts in the management of periodontitis has adverse complications, leading to seeking out naturopathic remedies. Although curcumin has been investigated in managing periodontitis, its therapeutic benefits have not been fully explored due to its limited solubility in an aqueous medium. This study aimed to develop a novel target-specific drug delivery system containing 1% self-nanoemulsifying curcumin (SNEC) in a hydroxypropylmethylcellulose (HPMC) matrix and evaluate the susceptibility of periodontal pathogens to this system in vitro. Methods. Its antibacterial activity against Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans was evaluated and compared to pure nano-curcumin and SNEC alone by estimating their minimum inhibitory concentrations (MIC). Results. The antibacterial activity of pure nano-curcumin, SNEC, and SNEC in HPMC against the four periodontal pathogens evaluated in terms of MIC was recorded in the range of 0.2‒0.4, 0.4‒0.8, and 0.2‒0.8 µg/mL, respectively. However, the MIC of all three curcumin formulations against the periodontal pathogens tested was higher than that of the standard moxifloxacin. While both pure nano-curcumin and SNEC showed increasing values of inhibition zones with increasing concentrations on disk diffusion assay, lower concentrations of SNEC in HPMC did not show a zone of inhibition against the tested pathogens. Conclusion. The novel delivery system containing SNEC in HPMC may be a potential adjunct in managing periodontitis due to its probable sustained antimicrobial activity against the tested periodontal pathogens.
format Article
id doaj-art-0045fa6d2f9941e88f078a5a0c3b110b
institution Kabale University
issn 2645-5390
language English
publishDate 2023-12-01
publisher Tabriz University of Medical Sciences
record_format Article
series Journal of Advanced Periodontology and Implant Dentistry
spelling doaj-art-0045fa6d2f9941e88f078a5a0c3b110b2024-12-11T06:00:45ZengTabriz University of Medical SciencesJournal of Advanced Periodontology and Implant Dentistry2645-53902023-12-01152677310.34172/japid.2023.024japid-3362Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro studyVeena HR0Riya Achamma Daniel1Ashwin Prabhu2Shilpa P3Suman Basavaraju4Department of Periodontology, KLE Society’s Institute of Dental Sciences, Bengaluru, KarnatakaDepartment of Dental Surgery, MIOT International, Chennai, IndiaDepartment of Periodontology, KLE Society’s Institute of Dental Sciences, Bengaluru, KarnatakaKLE Society’s Institute of Dental Sciences, Bengaluru, KarnatakaDepartment of Periodontology, JSS Dental College & Hospital, Mysuru, IndiaBackground. Long-term use of many classic chemotherapeutic agents as adjuncts in the management of periodontitis has adverse complications, leading to seeking out naturopathic remedies. Although curcumin has been investigated in managing periodontitis, its therapeutic benefits have not been fully explored due to its limited solubility in an aqueous medium. This study aimed to develop a novel target-specific drug delivery system containing 1% self-nanoemulsifying curcumin (SNEC) in a hydroxypropylmethylcellulose (HPMC) matrix and evaluate the susceptibility of periodontal pathogens to this system in vitro. Methods. Its antibacterial activity against Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans was evaluated and compared to pure nano-curcumin and SNEC alone by estimating their minimum inhibitory concentrations (MIC). Results. The antibacterial activity of pure nano-curcumin, SNEC, and SNEC in HPMC against the four periodontal pathogens evaluated in terms of MIC was recorded in the range of 0.2‒0.4, 0.4‒0.8, and 0.2‒0.8 µg/mL, respectively. However, the MIC of all three curcumin formulations against the periodontal pathogens tested was higher than that of the standard moxifloxacin. While both pure nano-curcumin and SNEC showed increasing values of inhibition zones with increasing concentrations on disk diffusion assay, lower concentrations of SNEC in HPMC did not show a zone of inhibition against the tested pathogens. Conclusion. The novel delivery system containing SNEC in HPMC may be a potential adjunct in managing periodontitis due to its probable sustained antimicrobial activity against the tested periodontal pathogens.https://japid.tbzmed.ac.ir/PDF/japid-15-67.pdfantibacterial agentscurcuminnanoparticlesperiodontitis
spellingShingle Veena HR
Riya Achamma Daniel
Ashwin Prabhu
Shilpa P
Suman Basavaraju
Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
Journal of Advanced Periodontology and Implant Dentistry
antibacterial agents
curcumin
nanoparticles
periodontitis
title Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
title_full Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
title_fullStr Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
title_full_unstemmed Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
title_short Susceptibility of periodontal pathogens to a novel target-specific drug delivery system containing self-nanoemulsifying curcumin: An in vitro study
title_sort susceptibility of periodontal pathogens to a novel target specific drug delivery system containing self nanoemulsifying curcumin an in vitro study
topic antibacterial agents
curcumin
nanoparticles
periodontitis
url https://japid.tbzmed.ac.ir/PDF/japid-15-67.pdf
work_keys_str_mv AT veenahr susceptibilityofperiodontalpathogenstoanoveltargetspecificdrugdeliverysystemcontainingselfnanoemulsifyingcurcuminaninvitrostudy
AT riyaachammadaniel susceptibilityofperiodontalpathogenstoanoveltargetspecificdrugdeliverysystemcontainingselfnanoemulsifyingcurcuminaninvitrostudy
AT ashwinprabhu susceptibilityofperiodontalpathogenstoanoveltargetspecificdrugdeliverysystemcontainingselfnanoemulsifyingcurcuminaninvitrostudy
AT shilpap susceptibilityofperiodontalpathogenstoanoveltargetspecificdrugdeliverysystemcontainingselfnanoemulsifyingcurcuminaninvitrostudy
AT sumanbasavaraju susceptibilityofperiodontalpathogenstoanoveltargetspecificdrugdeliverysystemcontainingselfnanoemulsifyingcurcuminaninvitrostudy